TY  - RPRT
TI  - Low-Dose CDK4/6 Inhibitors Induce Presentation of Pathway Specific MHC ligands as Targets for Cancer Immunotherapy
AU  - Charles, A.
AU  - Bourne, C.
AU  - Mun, S. S.
AU  - Dao, T.
AU  - Aretz, Z.
AU  - Korontsvit, T.
AU  - Klatt, M.
AU  - Scheinberg, D. A.
PY  - 2020
DO  - 10.1101/2020.06.18.157800
UR  - https://www.biorxiv.org/content/10.1101/2020.06.18.157800v1
ID  - 10.1101/2020.06.18.157800
ER  -